EUVIMEDEUVIMED entdecken
Crossref

Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway.

Y.R. Yang

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS · 2020

DOI: 10.23812//20-78-a-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020. Verfasst von Y.R. Yang.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yang, Y. (2020). Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. https://doi.org/10.23812//20-78-a-8

Vancouver

Yang Y. Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. 2020. doi:10.23812//20-78-a-8

BibTeX
@article{Yang2020,
  author = {Yang, Y.R.},
  title = {Cyclooxygenase-2 inhibitor rofecoxib prevents chondrocytes against hypertrophy via Wnt/β-catenin pathway},
  journal = {JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS},
  year = {2020},
  doi = {10.23812//20-78-a-8}
}
Kostenlos starten →